ClinicalTrials.Veeva

Menu

High Neutrophil-to-Lymphocyte Ratio and Patients With Hemodialysis

S

Sohag University

Status

Not yet enrolling

Conditions

Hemodialysis Patient

Treatments

Other: neutrophil lymphocyte ratio and platelet lymphocyte ratio

Study type

Observational

Funder types

Other

Identifiers

NCT07070557
Soh-Med--25-6-10MS

Details and patient eligibility

About

To explore the role of neutrophil-to-lymphocyte ratio ( NLR ) and platelet-to-lymphocyte ratio ( PLR ) in predicting mortality in hemodialysis (HD) patients.

Enrollment

100 estimated patients

Sex

All

Ages

18+ months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All cases with age ≥ 18 years from both sexes female and male, having end-stage renal disease (ESRD), who have been on hemodialysis for at least three months and divided to 4 groups according to the median of NLR and PLR

Exclusion criteria

  • • Patients aged < 18 years old.

    • Patient with autoimmune disease.
    • Patient with liver cirrhosis.
    • Patients with immunodeficiency.
    • Patients with malignancy.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems